US Stock MarketDetailed Quotes
ENLV Enlivex Therapeutics
- 1.323
- +0.033+2.57%
Close Jun 20 16:00 ET
27.62MMarket Cap-951P/E (TTM)
1.370High1.302Low75.97KVolume1.330Open1.290Pre Close101.55KTurnover0.42%Turnover RatioLossP/E (Static)20.87MShares4.59052wk High1.03P/B24.11MFloat Cap1.15052wk Low--Dividend TTM18.22MShs Float44.900Historical High--Div YieldTTM5.27%Amplitude1.150Historical Low1.336Avg Price1Lot Size
Enlivex Therapeutics News
Enlivex Therapeutics Analyst Ratings
HC Wainwright & Co. Maintains Buy on Enlivex Therapeutics, Lowers Price Target to $6
Enlivex Therapeutics Analyst Ratings
Enlivex Therapeutics Analyst Ratings
Enlivex Therapeutics Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Enlivex Therapeutics, Maintains $15 Price Target
Enlivex Therapeutics Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Enlivex Therapeutics, Maintains $15 Price Target
HC Wainwright & Co. Reiterates Buy on Enlivex Therapeutics, Maintains $15 Price Target
Enlivex Therapeutics Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Enlivex Therapeutics, Maintains $15 Price Target
H.C. Wainwright Sticks to Its Buy Rating for Enlivex Therapeutics (ENLV)
No More
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg